Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT

NCT03007732 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Prostatic Neoplasms

Interventions

DRUG: Pembrolizumab
DRUG: SD-101
DRUG: Leuprolide acetate
DRUG: Abiraterone Acetate
DRUG: Prednisone
RADIATION: Stereotactic Body Radiation Therapy

Sponsor

David Oh

Collaborators

[object Object]
[object Object]
[object Object]